Data complete?
Evaluation appropriate?
Number of things that still need to be reported to the doctor before starting therapy
Number of things that must not be left out in discussions with your doctor
Your chances of having a significant problem with histoplasmosis during TNF blocker therapy are
Caution: A qualified health practitioner should verify all results.Keep patient data confidential and comply with all legal requirements.
Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited
Purpose: To instruct a patient about to start tumor necrosis factor alpha (TNF alpha) blocker therapy on steps to help avoid histoplasmosis.
Specialty: Infectious Diseases
Objective: risk factors, response to therapy, prevention
ICD-10: B39,